Saptak chem & business Limited has announced the outcome of its board meeting held on March 17, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, conducted at the company's registered office in Ahmedabad, successfully approved multiple corporate governance matters that require subsequent shareholder approval.

Financial and Investment Approvals

The board has approved several significant financial decisions requiring regulatory compliance and shareholder consent. Key approvals include granting loans and investments under Section 186 of the Companies Act 2013, along with providing guarantees. The board also approved transactions under Section 185 of the Companies Act 2013 and related party transactions, all subject to subsequent approval from the company's shareholders.

Director Appointments and Leadership Changes

The board approved multiple director appointments and regularizations that will strengthen the company's management structure:

The appointment of Mr. Ayush Vinod Kumar Tated as Managing Director represents a significant leadership development, with the approved five-year term extending from January 9, 2026 to January 8, 2031.

Committee Reconstitution

The board approved the reconstitution of three key committees with Mr. Jignesh Keshav Barot as Chairman across all committees:

Audit Committee

Nomination and Remuneration Committee

Stakeholders' Relationship Committee

Postal Ballot and Governance Procedures

The board approved the draft notice for postal ballot along with the timeline for e-voting facility to obtain shareholder approvals for the proposed matters. Mrs. Rupal Patel, Practising Company Secretary, has been appointed as Scrutinizer for the postal ballot process, ensuring compliance with regulatory requirements for shareholder voting.

Meeting Details

The board meeting commenced at 1:30 PM and concluded at 4:45 PM on March 17, 2026. The outcome was signed by Mr. Jubin Premji Gada, Director (DIN: 10820579), demonstrating the company's adherence to regulatory disclosure requirements under SEBI regulations.

Saptak Chem & Business Limited successfully conducted its annual independent directors meeting on March 14, 2026, fulfilling mandatory regulatory requirements for the financial year 2025-26. The meeting was held at the company's registered office located at 6th Floor, B-Wing, B D Patel House, Naranpura, Ahmedabad.

Meeting Details and Compliance

The independent directors meeting was conducted in accordance with Regulation 25(3) of the Securities and Exchange Board of India (LODR) Regulations, 2015, read with Schedule IV of the Companies Act, 2013. The session commenced at 3:00 PM and concluded at 3:30 PM, spanning exactly 30 minutes.

Key Agenda Items Reviewed

The independent directors conducted a comprehensive evaluation covering multiple aspects of corporate governance and board effectiveness. The meeting addressed three primary areas of assessment as mandated by regulatory requirements.

The directors undertook the following evaluations:

• Board Performance Review: Assessed the performance of non-independent directors and evaluated the board of directors as a collective entity
• Leadership Assessment: Reviewed the performance of the company's chairperson, incorporating feedback from both executive and non-executive directors
• Information Flow Analysis: Evaluated the quality, quantity, and timeliness of information flow between company management and the board of directors

Regulatory Significance

This meeting represents a crucial component of the company's corporate governance framework, ensuring independent oversight of board operations and management effectiveness. The assessment of information flow between management and the board is particularly significant as it ensures directors can effectively discharge their fiduciary duties.

Company Information

Saptak Chem and Business Limited operates from its registered office in Ahmedabad and maintains active communication channels through its website www.saptakchem.com . The company's shares are listed on BSE Limited under scrip code 506906, and it operates under CIN L24299GJ1980PLC101976.